Home 5 About Cannvalate

Cannvalate was established in early 2018 by co-founders Sud Agarwal, Asaf Katz and Darryl Davies. Bringing together a team of expert medical professionals and leaders in the medicinal cannabis industry, Cannvalate quickly became one of Australia’s leading cannabis companies. Cannvalate is passionate about connecting suppliers of medicinal cannabis with doctors and pharmacies & easing.

the way for patients who could benefit from these treatments. Though medicinal cannabis was legalised in 2016, at the end of 2018 only 1,300 scripts had been written. Cannvalate streamlines the process to increase accessibility to medicinal cannabis and allow patients to receive the treatments they need more easily. With operations across Australia, New Zealand and soon the United Kingdom, Cannvalate provides expert services across the entire breadth of the industry.

Management Team

Dr Sud Agarwal

Chairman & Chief Executive Officer

MB ChB (UK), BSc (Hons) FANZCA (Royal Melbourne Hospital)

  • Specialist Anaesthesiologist
  • Former Medical Director–Cann Group (ASX:Cann)
  • Healthcare commercialisation specialist
  • 3x Healthcare Commercialisation Exits

Mr Darryl Davies

Chief Operating Officer

BSc (Hons)

  • Government Medicinal Cannabis Strategist.
  • Cannabis Harm-minimisation Lead Specialist in the UK
  • Cann10 Program Director – Education Lead
  • Multi-Award-winning Educational Events Coordinator

Dr Gal Wong

Chief Medical Officer

MBBS, BMedScm GCAP, PGDipSurgAnat

  • Professional Medical Educator University of Melbourne and Monash University Lecturer
  • Designer of blended learning modules (DMIRS)
  • Graduate degree in tertiary (adult) education (GCAP)

Prof Con Stough

Chief Scientific Officer

BSc, PhD

  • Global Expert in Cognitive Neuroscience and Psychology
  • Director of Human Psychopharmacology at Swinburne Centre for Neuropsychology
  • Over 500 Peer Reviewed Publications in the Fields of Illicit Drug use & Australia’s Highest Published Author on Cannabis Drugs

Mr James Ostroburski

Non – Executive Director

BBus (Comm Law), Dip Fin Planning, Post Grad Corporate (NYU)

  • Head of Medical Finance, Grimsey Wealth (2015 – 2016)
  • Chief Executive, Kooyong Group (2017–current)
  • Trustee, Arts Centre Melbourne Foundation (2013 – 2015)
  • Director, Jewish Museum of Australia (2016 – current)

Mr Divesh Sanghvi

Non-Executive Director & Head of Pharmacy

BPharm MPS

  • Proprietor of Multiple Pharmacies
  • Director of GPD Primary Health Pty Ltd
  • Managing Director of Member Benefits Australia Pty Ltd
  • Ex Committee Member of Monash Pharmacy Faculty

Advisory Board

Dr Luke Crantock


  • Specialist Gastrointestinologist
  • Sub-specialist inflammatory bowel disease
  • Clinical research interests: IBD

Dr Umberto Rossi


  • Specialist Neurosurgeon
  • Clinical interests: non-operative management of neurosurgical pathology

Dr Simon Hinckfuss

D.Clin.Dent N.Sc(MN), Cert.Perio(MN)

Dr Ty-Ron Ching


  • General Practitioner and Forensic Doctor
  • Clinical interests: addiction medicine, prison medicine, & polypharmcy

Dr Adrian Fox

Fracs, MB, BS (Hons)

  • Specialist Hepatobiliary Surgeon and General Surgeon, and Fellow at Royal Australian College of Surgeons
  • Research interests: pancreatic cancer, complex HCC & cholangiocarcinoma

Dr James Chiu

Fracs, MB, BS (Hons)

  • Orthopaedic Surgeon and Knee & Shoulder Specialist
  • Clinical interests: cannabinoinds for postoperative analgesia & prevention of chronic pain

Prof Michael Keane


  • Professor of Medicine & Therapeustics at UCD and Consultant Specialist Anesthesiologist